A previous study indicated that circ‐MELK could promote the mesenchymal transition of GBM cells and maintain the roles of tumour stem cells by targeting EPH receptor B2 (EphB2) via sponging miR‐593.124. The gene discussed is EPHB2; the disease is glioblastoma.